| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vaccibody AS (OL: VACC)
VACC Technical Analysis
4
| As on 16th Dec 2021 VACC STOCK Price closed @ 78.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 73.05 & Strong Buy for SHORT-TERM with Stoploss of 61.34 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VACCSTOCK Price
| Open | 77.50 | Change | Price | % |
| High | 79.90 | 1 Day | 1.00 | 1.30 |
| Low | 77.50 | 1 Week | 3.70 | 4.98 |
| Close | 78.00 | 1 Month | 12.80 | 19.63 |
| Volume | 222525 | 1 Year | 19.00 | 32.20 |
| 52 Week High 91.25 | 52 Week Low 47.00 | ||||
OL Norway Most Active Stocks
| BELCO | 20.25 | 27.84% |
| NEL | 3.04 | 0.00% |
| AOW | 2.00 | -5.21% |
| KOA | 1.84 | -2.65% |
| ASA | 0.09 | 0.00% |
| RECSI | 3.24 | 14.89% |
| IDEX | 0.13 | -7.14% |
| NHY | 62.36 | 0.03% |
| ACC | 6.19 | 4.92% |
| NAS | 10.88 | -0.91% |
OL Norway Top Gainers Stocks
OL Norway Top Losers Stocks
| VACC Daily Charts |
VACC Intraday Charts |
Whats New @ Bazaartrend |
VACC Free Analysis |
|
|
VACC Important Levels Intraday
| RESISTANCE | 82.62 |
| RESISTANCE | 81.14 |
| RESISTANCE | 80.22 |
| RESISTANCE | 79.31 |
| SUPPORT | 76.69 |
| SUPPORT | 75.78 |
| SUPPORT | 74.86 |
| SUPPORT | 73.38 |
VACC Forecast December 2024
| 4th UP Forecast | 118.47 |
| 3rd UP Forecast | 105.49 |
| 2nd UP Forecast | 97.47 |
| 1st UP Forecast | 89.45 |
| 1st DOWN Forecast | 66.56 |
| 2nd DOWN Forecast | 58.53 |
| 3rd DOWN Forecast | 50.51 |
| 4th DOWN Forecast | 37.53 |
VACC Weekly Forecast
| 4th UP Forecast | 99.14 |
| 3rd UP Forecast | 92.36 |
| 2nd UP Forecast | 88.17 |
| 1st UP Forecast | 83.98 |
| 1st DOWN Forecast | 72.02 |
| 2nd DOWN Forecast | 67.83 |
| 3rd DOWN Forecast | 63.64 |
| 4th DOWN Forecast | 56.86 |
VACC Forecast2024
| 4th UP Forecast | 170.5 |
| 3rd UP Forecast | 140.83 |
| 2nd UP Forecast | 122.5 |
| 1st UP Forecast | 104.16 |
| 1st DOWN Forecast | 51.84 |
| 2nd DOWN Forecast | 33.5 |
| 3rd DOWN Forecast | 15.17 |
| 4th DOWN Forecast | -14.5 |
Vaccibody AS ( OL Norway Symbol : VACC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VACC Business Profile
Vaccibody AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of melanoma, lung, head and neck, renal, and bladder; and VB10.16, a therapeutic DNA vaccine for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer. The company has clinical collaboration agreements with Roche and Nektar Therapeutics. Vaccibody AS was founded in 2007 and is based in Oslo, Norway. Address: Oslo Research Park, Oslo, Norway, 0349
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service